Range Low Price High Price Comment
30 days $83.44 $92.16 Wednesday, 27th Mar 2024 BMRN stock ended at $88.61. This is 0.99% more than the trading day before Tuesday, 26th Mar 2024. During the day the stock fluctuated 0.90% from a day low at $87.94 to a day high of $88.74.
90 days $83.44 $99.25
52 weeks $76.02 $100.38

Historical BioMarin Pharmaceutical Inc. prices

Date Open High Low Close Volume
2021-07-21 $79.48 $80.01 $78.44 $79.65 678 389
2021-07-20 $79.25 $80.17 $78.95 $79.50 1 168 786
2021-07-19 $77.39 $79.24 $77.35 $78.77 1 045 997
2021-07-16 $79.95 $80.06 $78.45 $78.84 851 637
2021-07-15 $79.39 $79.99 $78.29 $79.57 1 381 176
2021-07-14 $81.66 $81.78 $79.58 $79.68 942 515
2021-07-13 $81.99 $82.39 $81.22 $81.50 495 206
2021-07-12 $83.84 $83.84 $81.81 $82.33 611 835
2021-07-09 $83.13 $83.72 $82.79 $83.62 604 678
2021-07-08 $82.26 $83.58 $81.50 $82.95 1 014 679
2021-07-07 $84.75 $84.80 $82.88 $83.04 1 167 706
2021-07-06 $85.35 $85.35 $84.00 $84.57 823 441
2021-07-02 $84.23 $85.74 $83.46 $85.47 946 784
2021-07-01 $83.26 $83.95 $82.97 $83.91 827 224
2021-06-30 $83.42 $83.82 $82.75 $83.44 769 485
2021-06-29 $84.23 $85.20 $82.96 $83.46 606 263
2021-06-28 $85.79 $86.33 $83.87 $84.43 519 316
2021-06-25 $84.33 $85.50 $83.20 $84.79 3 891 045
2021-06-24 $83.23 $84.17 $82.91 $83.78 1 081 544
2021-06-23 $80.79 $82.87 $80.79 $82.58 1 252 233
2021-06-22 $80.92 $81.53 $80.14 $81.14 1 197 969
2021-06-21 $82.06 $82.60 $80.43 $80.76 1 092 492
2021-06-18 $82.54 $82.90 $81.52 $81.90 1 339 902
2021-06-17 $82.54 $83.76 $82.04 $82.98 820 917
2021-06-16 $82.13 $82.68 $81.35 $82.48 1 028 627
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT